Loading...
Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis
Galectin (Gal)-3 is a profibrotic β-galactoside-binding lectin that plays a key role in the pathogenesis of idiopathic pulmonary fibrosis (IPF) and IPF exacerbations. TD139 is a novel and potent small-molecule inhibitor of Gal-3. A randomised, double-blind, multicentre, placebo-controlled, phase 1/2...
Na minha lista:
| Udgivet i: | Eur Respir J |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
European Respiratory Society
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8156151/ https://ncbi.nlm.nih.gov/pubmed/33214209 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.02559-2020 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|